Yunnan Botanee Bio-Technology Group Co

Yunnan Botanee Bio-Technology Group Co FCF per Share

The Free Cash Flow per Share of Yunnan Botanee Bio-Technology Group Co (300957.SZ) as of Oct 31, 2026 is 1.18 CNY. In the previous year, Free Cash Flow per Share was 0.77 CNY — a change of 53.03% (higher).

FCF per Share

1.18CNY

YoY

53.03%

Last updated:

Free Cash Flow per Share of Yunnan Botanee Bio-Technology Group Co is 2025 1.18 CNY. Free Cash Flow per Share of Yunnan Botanee Bio-Technology Group Co was 2024 0.77 CNY. It decreases by 53.03% higher compared to the previous year.

The Yunnan Botanee Bio-Technology Group Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
0.17 CNY
Jan 1, 2019
1.26 CNY
Jan 1, 2020
0.96 CNY
Jan 1, 2021
2.47 CNY
Jan 1, 2022
0.98 CNY
Jan 1, 2023
0.80 CNY
Jan 1, 2024
0.77 CNY
Jan 1, 2025
1.18 CNY
The Yunnan Botanee Bio-Technology Group Co FCF per Share history
YEARFCF per ShareYoY
1.18CNY+53.03%
0.77CNY-3.57%
0.80CNY-18.89%
0.98CNY-60.23%
2.47CNY+158.23%
0.96CNY-24.32%
1.26CNY+651.06%
0.17CNY-62.59%
0.45CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yunnan Botanee Bio-Technology Group Co Stock analysis

What does Yunnan Botanee Bio-Technology Group Co do? Yunnan Botanee Bio-Technology Group Co., Ltd. generates revenue through the research, development, manufacture, and sales of skin care products and services. The company's product portfolio includes creams, skin care lotions, facial masks, essences, lotions, and makeup items such as isolation creams, blemish balm (BB) creams, and makeup removers. Additionally, it offers medical device products like hyaluronic acid repairing biofilm and hyaluronic acid repairing dressings, designed for skin barrier protection post-minimally invasive surgery. Sales are driven by both offline and online channels, with the firm focusing on these distribution methods as key revenue streams. The company targets consumers seeking skincare solutions, particularly those requiring post-surgical skin care, through its medical device line. Its product range caters to a broad market segment, including daily skincare users and individuals needing specialized care for skin conditions. The firm's emphasis on both conventional skincare and medical-grade products allows it to address diverse consumer needs across multiple segments. Yunnan Botanee's revenue model relies on direct sales of its skincare and medical device products, with no mention of external partnerships or third-party branding. The company's focus on in-house R&D and manufacturing ensures control over product quality and pricing, supporting consistent revenue generation from its established customer base. Yunnan Botanee Bio-Technology Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yunnan Botanee Bio-Technology Group Co stock

Free Cash Flow per Share of Yunnan Botanee Bio-Technology Group Co is 1.18 CNY in 2025.

Free Cash Flow per Share of Yunnan Botanee Bio-Technology Group Co changed from 0.77 CNY to 1.18 CNY, representing a 53.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Yunnan Botanee Bio-Technology Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Yunnan Botanee Bio-Technology Group Co

All Key Metrics — Yunnan Botanee Bio-Technology Group Co